Construction of nanoscale multicompartment liposomes for combinatory drug delivery

被引:39
作者
Al-Jamal, Wafa' T. [1 ]
Kostarelos, Kostas [1 ]
机构
[1] Univ London, Sch Pharm, Ctr Drug Delivery Res, Nanomed Lab, London WC1N 1AX, England
关键词
multicompartment liposomes; cancer therapy; combinatory chemotherapy; multimodal delivery; theranostic;
D O I
10.1016/j.ijpharm.2006.11.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liposomes are clinically used delivery systems for chemotherapeutic agents, biological macromolecules and diagnostics. Due to their flexibility in size and composition, different types of liposomes have been developed varying in surface and structural characteristics. Multi compartment liposomes constitute an attractive drug carrier system offering advantages in terms of inner vesicle protection, sustained drug release and possibility for combinatory (cocktail) therapies using a single delivery system. However, all previously described methodologies for multicompartment or multivesicular liposomes resulted in micrometer-sized vesicles limiting most pharmaceutical applications. In this work we report formulation of nanoscale multicompartment liposomes which maybe applicable for systemic administration. A small unilamellar vesicle (SUV) aqueous dispersion (DOPC:DOPG:CHOL) was used to hydrate a dried film of different lipid contents (DMPC:CHOL), followed by extrusion. The system was characterised by techniques such as photon correlation spectroscopy (PCS), zeta potential measurement, transmission electron microscopy (TEM) and laser scanning confocal microscopy (LSCM). We observed a single, multi compartment vesicle population composed of the two different bilayer types of approximately 200 nm in mean diameter rather than a mixture of two independent vesicle populations. In the case of tumour therapy, such multicompartment liposome systems can offer a single carrier for the delivery of two different modalities. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:182 / 185
页数:4
相关论文
共 15 条
[1]   PHARMACOKINETICS OF LONG-CIRCULATING LIPOSOMES [J].
ALLEN, TM ;
HANSEN, CB ;
DEMENEZES, DEL .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :267-284
[2]   Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release [J].
Andresen, TL ;
Jensen, SS ;
Jorgensen, K .
PROGRESS IN LIPID RESEARCH, 2005, 44 (01) :68-97
[3]   Preparation of novel double liposomes using the glass-filter method [J].
Katayama, K ;
Kato, Y ;
Onishi, H ;
Nagai, T ;
Machida, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 248 (1-2) :93-99
[4]   PREPARATION OF MULTIVESICULAR LIPOSOMES [J].
KIM, S ;
TURKER, MS ;
CHI, EY ;
SELA, S ;
MARTIN, GM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 728 (03) :339-348
[5]   Nanocompartments enclosing vesicles, colloids, and macromolecules via interdigitated lipid bilayers [J].
Kisak, ET ;
Coldren, B ;
Zasadzinski, JA .
LANGMUIR, 2002, 18 (01) :284-288
[6]  
Lasic D., 1998, Medical Applications of Liposomes
[7]   Colloid chemistry - Liposomes within liposomes [J].
Lasic, DD .
NATURE, 1997, 387 (6628) :26-27
[8]   A lipid based depot (DepoFoam® technology) for sustained release drug delivery [J].
Mantripragada, S .
PROGRESS IN LIPID RESEARCH, 2002, 41 (05) :392-406
[9]   Development of novel fusogenic vesosomes for transcutaneous immunization [J].
Mishra, Vivek ;
Mahor, Sunil ;
Rawat, Amit ;
Dubey, Praveen ;
Gupta, Prem N. ;
Singh, Paramjit ;
Vyas, Suresh P. .
VACCINE, 2006, 24 (27-28) :5559-5570
[10]  
Ramsay Euan C., 2005, Current Drug Delivery, V2, P341, DOI 10.2174/156720105774370294